Is Golimumab Plus Methotrexate More Effective in Early PsA? – Medscape
… Rheumatology (ACR) response criteria assessed at 12, 24, 36, and 52 weeks. TAKEAWAY: At week 24, no significant difference […]
… Rheumatology (ACR) response criteria assessed at 12, 24, 36, and 52 weeks. TAKEAWAY: At week 24, no significant difference […]
“This study builds on years of work identifying and tracking people at risk for RA,” said Kevin Deane, MD, professor
Treatment responses were assessed based on the percent of improvements in the American College of Rheumatology (ACR), Assessment of …
QD Clinic: Stick or twist (when not to change treatment Dr. Richard Conway, Dublin, discusses a case about when not
Rheum to Breathe Journal Club tammytilley@gm… Wed, 09/24/2025 – 13:32 Education/ACR/EULAR Drug Safety Novel Rx Other Rheumatoid Arthritis Scleroderma/Raynauds This
Assessing ILD in Rheumatology Janet Pope, MD, shares practical insights on how rheumatologists should assess ILD in the https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john…
Scleroderma-associated Interstitial Lung Disease Since the first placebo-controlled randomized trial published nearly https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Wed, 09/24/2025 – 11:30 RheumNow Dr.
Dr. Courtney Stull Cottage Health has opened Cottage Rheumatology Clinic, a new specialty care clinic within Cottage Medical Group.
Moral courage is the strength to speak up even when doing so may have negative consequences. This is vital skill
In this episode, Dr. Kumar talks about the fascinating and intriguing secret lives of rheumatologists—real life superheroes. The post <em>Rheum
Greater comorbidity burden (per Rheumatic Disease Comorbidity Index point: aHR, 1.26; 95% CI, 1.25-1.27);; Use of urate-lowering therapy (aHR, 1.30; …
Panel of IPF assoc 8 biomarkers (eotaxin, Flt-3L, IL-8, MDC, MCP-1, MMP-2/7/9) tested in 2 RA-ILD cohorts (n 164). IPF
QD Clinic: ILD with Positive SSA and Rash tammytilley@gm… Wed, 09/24/2025 – 08:00 Education/ACR/EULAR Other Cardio/Pulmonary Dermatology Dr. Elena Joerns,
… Rheumatology (ACR) Convergence 2025 being held October 24 – 29 in Chicago, IL. “With the significant prevalence of chronic
Rheumatol Int. 2025 Sep 24;45(10):233. doi: 10.1007/s00296-025-05959-4. ABSTRACT Limited psychosocial support is available for people with lupus despite the highly
Int Ophthalmol. 2025 Sep 24;45(1):382. doi: 10.1007/s10792-025-03775-0. ABSTRACT PURPOSE: To evaluate choroidal and retinal ultrastructural and microvascular changes in patients
Rheumatol Int. 2025 Sep 24;45(10):236. doi: 10.1007/s00296-025-05987-0. ABSTRACT The prevalence of non-alcoholic fatty liver disease (NAFLD) in patients with rheumatoid
Rheumatol Int. 2025 Sep 24;45(10):235. doi: 10.1007/s00296-025-05989-y. ABSTRACT Methotrexate (MTX) is a widely prescribed disease-modifying antirheumatic drug (DMARD) used at
Rheumatol Int. 2025 Sep 24;45(10):237. doi: 10.1007/s00296-025-05988-z. ABSTRACT OBJECTIVES: Interstitial lung disease (ILD), one of the complications of rheumatoid arthritis
Z Rheumatol. 2025 Sep 24. doi: 10.1007/s00393-025-01727-8. Online ahead of print. ABSTRACT In April 2025, the European Alliance of Associations
Rev Assoc Med Bras (1992). 2025 Sep 19;71(8):e20250181. doi: 10.1590/1806-9282.20250181. eCollection 2025. ABSTRACT OBJECTIVE: Juvenile idiopathic arthritis is the most
Int J Surg. 2025 Sep 24. doi: 10.1097/JS9.0000000000003300. Online ahead of print. ABSTRACT BACKGROUND: Tophi, a severe complication of advanced
Int J Surg. 2025 Sep 24. doi: 10.1097/JS9.0000000000003450. Online ahead of print. ABSTRACT BACKGROUND: Recent evidence has raised concerns about
ACS Nano. 2025 Sep 24. doi: 10.1021/acsnano.5c10112. Online ahead of print. ABSTRACT Bioactive hydrogels with anti-inflammatory, antioxidant, and pro-angiogenic properties
Laryngoscope. 2025 Sep 24. doi: 10.1002/lary.70167. Online ahead of print. ABSTRACT OBJECTIVE (S): Idiopathic and granulomatosis with polyangiitis (GPA)-related subglottic
Lupus. 2025 Sep 24:9612033251379310. doi: 10.1177/09612033251379310. Online ahead of print. ABSTRACT BackgroundAntiphospholipid syndrome (APS) is the most common acquired hypercoagulable